Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Clinical Pharmacology in Drug Development|July 2, 2016
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or AripiprazoleBart Remmerie, Marc De Meulder, Sveta Weiner, et al.Clinical Pharmacology in Drug Development|July 2, 2016
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or AripiprazoleBart Remmerie, Marc De Meulder, Jay Ariyawansa, et al.Journal of Clinical Pharmacology|September 29, 2015
Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric DisordersBart Remmerie, Jay Ariyawansa, Marc De Meulder, et al.Bioanalysis|July 7, 2020
Capillary microsampling in clinical studies: opportunities and challenges in two case studiesTom Verhaeghe, Marc De Meulder, Vera Hillewaert, et al.Clinical Pharmacology in Drug Development|April 30, 2026
A Phase 1, Open-Label, Single-Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR InhibitorWei Zhu, Peter Hellemans, Anna Mitselos, et al.Clinical Pharmacokinetics|July 4, 2023
Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid PretreatmentPeter Zannikos, Bhavna Solanki, Marc De Meulder, et al.Journal of Clinical Pharmacology|April 23, 2026
Effect of Once-Daily Macitentan 75 mg on the Pharmacokinetics of Sildenafil, Riociguat, or Rosuvastatin in Healthy Male ParticipantsDénes Csonka, Cynthia Gargano, Navin Goyal, et al.Clinical Pharmacology in Drug Development|December 27, 2019
Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With SchizophreniaHiroko Shimizu, Martine Neyens, Marc De Meulder, et al.Clinical Drug Investigation|April 21, 2015
Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy MenPrasarn Manitpisitkul, Arthur Mayorga, Kevin Shalayda, et al.Bioanalysis|August 1, 2014
Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissuesNathalie Mokrzycki, Pascal Delrat, Marc De Meulder, et al.Pageof 3